
What’s the Fed’s Next Move?
Real Vision: Finance & Investing
00:00
Potential Rescheduling of Psilocybin and MDMA
Discussion on the potential rescheduling of psilocybin and MDMA by the FDA for the treatment of psychiatric illnesses, and the increasing evidence supporting their effectiveness in treating PTSD.
Play episode from 26:01
Transcript


